Skip to content
sellModerate

Dorothy Trefon Capers sold $1.5M of XYL

SVP & General Counsel at Xylem Inc.. 12,026 shares at an average of $127.26, traded Mar 4, 2025, filed Mar 6, 2025.

Warning score
45
Value
$1.5M
12,026 shares
Holdings after
8,015
-60% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $1.5M at market
    +25
  • Share of holdings sold
    Sold 60% of holdings
    +20
  • Cluster
    No other insider selling within 14 days
    0
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

XYLOct 9, 2026 · close 102.71
Since filing Mar 6, 2025: -18.8%SPY +38.6% · excess -57.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001562180-25-002143, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 4, 2025MOption exercise
Common Stock
+7,868$86.76$683k15,883Mar 6, 2025
Mar 4, 2025MOption exercise
Common Stock
+4,158$101.09$420k20,041Mar 6, 2025
Mar 4, 2025SOpen-market sale
Common Stock
-12,026$127.26$1.5M8,015Mar 6, 2025
Mar 5, 2025AGrant or award
Common Stock
+1,398$129.67$181k9,413Mar 6, 2025
Mar 4, 2025MOption exercise
Non-Qualified Stock Option (Right to Buy)derivative
-4,158$0.00$02,079Mar 6, 2025
Mar 4, 2025MOption exercise
Non-Qualified Stock Option (Right to Buy)derivative
-7,868$0.00$00Mar 6, 2025
Mar 5, 2025AGrant or award
Non-Qualified Stock Options (Right to buy)derivative
+4,905$129.67$636k4,905Mar 6, 2025

Related signals

Other insiders at Xylem Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
36Weak
XYLsell 2
Xylem Inc.
Victoria D Harker
director
$252k
1,700 shares
-9%
58Moderate
XYLsell 2
Xylem Inc.
Claudia S Toussaint
EVP, CPSO
$1.6M
10,421 shares
-25%
36Weak
XYLsell
Xylem Inc.
Geri-Michelle McShane
VP, CAO
$140k
1,000 shares
-25%
54Moderate
XYLsell 2
Xylem Inc.
Lisa Glatch
director
$689k
4,900 shares
-49%
36Weak
XYLsell 2
Xylem Inc.
Victoria D Harker
director
$259k
1,800 shares
-9%
10Weak
XYLbuy
Xylem Inc.
Lila Tretikov
director
$528
4 shares
+0%
15Weak
XYLsell
Xylem Inc.
Lila Tretikov
director
$480
4 shares
-0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dorothy Trefon Capers sold $1.5M of XYL | InsiderTell